Dementia News and Research

Latest Dementia News and Research

Selective restraints and reduced medication could reduce nursing home falls

Selectively restraining elderly residents and giving them fewer sleeping pills could significantly reduce falls, according to a survey of 21 nursing home units published in the January issue of Journal of Clinical Nursing.

15 Jan 2008

New guidelines to improve palliative care at the end of life

The American College of Physicians (ACP) has issued new guidelines to improve palliative care at the end of life (EOL).

15 Jan 2008

People with dementia survive on average four and a half years after diagnosis

People with dementia survive an average of four and a half years after diagnosis, with age, sex, and existing disability all having an influence on life expectancy, finds a study published on bmj.com.

15 Jan 2008

Etanercept drug reverses early symptoms of Alzheimer's in 10 minutes

Scientists in the U.S. say a drug which can reverse some of the early symptoms of Alzheimer's disease takes effect within 10 minutes.

14 Jan 2008

Memantine and Alzheimer's

In a study published this month in the Journal of Alzheimer's Disease, researchers from the University of Aberdeen report that the drug memantine, used for the treatment of Alzheimer's disease and praised as "the first and only representative of a new class of Alzheimer drugs" works in fact similar to other existing compounds, and is beneficial only in a narrow concentration range.

14 Jan 2008

Barr Pharmaceuticals confirms patent challenge of Namenda tablets

Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patent listed by Forest Laboratories, Inc. in connection with its Namenda (memantine hydrochloride) tablets, 5mg and 10mg.

14 Jan 2008

Review of Memantine for Alzheimer's

11 Jan 2008

New study highlights importance soluble proteins, called cytokines, in Alzheimer's

An extraordinary new scientific study, which for the first time documents marked improvement in Alzheimer's disease within minutes of administration of a therapeutic molecule, has just been published in the Journal of Neuroinflammation .

10 Jan 2008

Testosterone levels may affect men's cognitive performance

When we think about the powers of testosterone, we usually do not consider mental processes.

8 Jan 2008

Congestive heart failure leads to greater disability, nursing home admissions

Medical breakthroughs in recent decades have allowed heart attack survivors and other heart-disease patients to live longer.

8 Jan 2008

Congestive heart failure leads to greater disability among older adults

Medical breakthroughs in recent decades have allowed heart attack survivors and other heart-disease patients to live longer. But as their hearts decline into congestive heart failure, an increasing number will experience disability and the need for nursing-home care.

7 Jan 2008

Testosterone therapy and mental function in healthy older men

When we think about the powers of testosterone, we usually do not consider mental processes.

3 Jan 2008

AstraZeneca submits sNDAs for SEROQUEL XR for bipolar symptoms

AstraZeneca has announced that the company has submitted two separate supplemental New Drug Applications (sNDAs) to the U.S. Food and Drug Administration (FDA) for once-daily SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of manic episodes associated with bipolar disorder and the treatment of depressive episodes associated with bipolar disorder.

3 Jan 2008